SEEL

Seelos Therapeutics, Inc. Common Stock
SEEL

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

SEEL was delisted on the 15th of October, 2024.

Back to rankings

20 hedge funds and large institutions have $2.55M invested in Seelos Therapeutics, Inc. Common Stock in 2020 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $
Holders
20
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$689K
2
+$249K
3
+$94K
4
1CM
1492 Capital Management
Wisconsin
+$74K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$41.4K

Top Sellers

1
-$41K
2
-$18.8K
3
-$2K
4
Squarepoint
Squarepoint
New York
-$1.8K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$1.01M
2
$529K
3
$249K
4
$210K
5
$158K
6
$94K
7
$75K
8
$74K
9
$34K
10
$17K
11
$17K
12
$15K
13
$14K
14
$14K
15
$10K
16
$9K
17
$6K
18
$6K
19
$1K
20
$1K
21
$1K
22
–